Molecular quality controls is ideally a process used to monitor and evaluate the analytical process that produces the patient results. It is mostly used for analyzing each assay running and verify the precise results. The growing technology advancement and increasing prevalence of Infectious Diseases, Oncology across the North America region has accelerated the demand for molecular quality controls market. Furthermore, growing demand for personalized medicine has significantly contributed in the growth of market. The growing adoption of market across the region is propelling the growth of market during the forecast period.
The North America’s molecular quality controls is driven by increasing number of accredited clinical laboratories across the region where number of accredited clinical laboratories are implementing molecular quality controls products for their testing process in different infectious diseases, oncology diseases among others has led the demand for market in region. Likewise, growing adoption of third-party quality controls and rising demand for external quality assessment support are the key factor propelling the growth of North America molecular quality controls market
The exclusive COVID 19 impact analysis report by Axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the North America molecular quality controls market. In addition, complete analysis of changes on the North America molecular quality controls market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on global economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The COVID-19 pandemic has provided a positive growth for market as number of laboratories were having increasing requirement molecular quality controls products.
The molecular quality controls market comprises of different market segment like product, analyte type, application, end users and country.
By product, the molecular quality controls market includes key segment of independent controls, instrument-specific controls. Instrument-specific Controls segment further includes PCR, DNA Sequencing & NGS and Other Technologies. Independent controls is expected to dominate in the market attributing to rising application of segment in different molecular testing for example, COVID-19. Furthermore, it majorly provides an ability to enhance the performance with level of standardization. Additionally, instrument-specific controls is expected to witness the growth at moderate pace during the forecast period.
The molecular quality controls market, includes different analyte type like single-analyte controls, multi-analyte controls. Multi-Analyte Controls accounted for major share in the North America molecular quality controls market. The factors driving the market growth are increasing preference for the segment in different end user like clinical laboratories, hospitals, among others has led the demand for segment in the market. Furthermore, cost effectiveness and wide range of formats are some of key factor providing ample of growth opportunity North America molecular quality controls market. Additionally, single-analyte controls is likely to witness new growth avenue during the estimated time period.
The molecular quality controls market finds its major application in infectious diseases, oncology, genetic testing and others. Infectious diseases leads in North America market due to growing burden of different diseases. Furthermore, rising patient burden in hospitals, clinical laboratories has led the demand for the molecular quality controls market. Also, infectious diseases has growing requirement for diagnosis along molecular quality controls to precise identify the type of diseases by which further treatment can be taken. Likewise, oncology increasing cases has created lucrative growth for market thereby helping in reducing the burden of diseases in the region.
The molecular quality controls market has different end user like clinical laboratories, hospitals, ivd manufacturers & cros, academic and research institutes. Clinical laboratories has gained major market share in the molecular quality controls market attributing to increasing requirement from segment for precise quality control products in testing of products has ultimately led the demand for North America molecular quality controls market. Furthermore, rising patient sample for diseases diagnosis, and patient requirement for precise laboratories results has created the surge and demand for molecular quality controls market in the region. Hospitals is expected to hold second position in the market owing to growing adoption of different laboratories within the areas in hospital for diagnosis and requirement for molecular quality controls to estimate precise results has led the demand for North America molecular quality controls market.
North America molecular quality controls market is studied for the following countries like United States, Canada and Mexico. In North America market, the molecular quality controls is witnessing emerging demand owing to rising burden of different infectious diseases in the region. Furthermore, in North America, United States has dominated the market in 2020 and is likely to witness growth at highest pace during the estimated time period. The presence of well-developed healthcare infrastructure, and growing number of clinical laboratories adopting the molecular quality controls products has significantly fuelled the demand for market. Similarly, Canada is anticipated to experience rising demand for market owing to growing number patient diagnosis and sample collection in the country. The rapid adoption of products in the country will the fuelled the growth of North America Molecular Quality Controls Market.
The key players in molecular quality controls market are Seracare Life Sciences Inc., Thermo Fisher Scientific, Bio-Rad Laboratories, Microbiologics Inc., Zeptometrix, Roche Diagnostics, Abbott Laboratories, Quidel, Qnostics and Maine Molecular Quality Controls Inc. among others.
June 2021: LGC SeraCare had expanded its line of SARS-CoV-2 molecular quality solutions to include AccuPlex SARS-CoV-2 Variant Panel 1. The kit contains full SARS-CoV-2 genomic RNA with a focus on S-gene mutations in three prominent variants of concern with vials.
March 2021: The Abbott Laboratories had announced U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for the company's Alinity m Resp-4-Plex molecular assay to detect and differentiate SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus (RSV) in one test. Alinity m uses Polymerase Chain Reaction (PCR) technology, which is known for its high sensitivity in detecting infectious diseases.
May 2020: ZeptoMetrix had announced the development and release of a ready-to-use SARS-CoV-2 molecular quality control formulated with purified intact viral particles that have been chemically modified to render them non-infectious and refrigerator stable
July 2018: Quidel had announced that it received 510(k) clearance from the United States Food and Drug Administration (FDA) to market its Solana Bordetella Complete Assay, a molecular diagnostic assay to be used with the Solana molecular diagnostic instrument for the qualitative detection and differentiation of Bordetella pertussis and Bordetella parapertussis nucleic acids isolated from nasopharyngeal swab specimens obtained from patients suspected of having a respiratory tract infection.
The report analyses the North America molecular quality controls market based on by product, analyte type, application, end users and country.
Why to buy this report: